The Emerging Role of EVA1A in Different Types of Cancers

International Journal of Molecular Sciences

Huijie Zhao¹  Honggang Wang²  Yihan Yang²  Huiyang Liu² 

[1] Institute of Chronic Disease Risks Assessment, Henan University, Jinming Avenue, Kaifeng 475004, China;School of Basic Medical Sciences, Henan University, Kaifeng 475004, China;

关键词: EVA1A;    autophagy;    triple-negative breast cancer;    papillary thyroid cancer;    non-small cell lung cancer;    hepatocellular carcinoma;   

DOI  :  10.3390/ijms23126665

来源: DOAJ

【 摘 要 】

Eva-1 homolog A (EVA1A), also known as transmembrane protein 166 (TMEM166) and regulator of programmed cell death, is an endoplasmic reticulum associated protein, which can play an important role in many diseases, including a variety of cancers, by regulating autophagy/apoptosis. However, the related mechanism, especially the role of EVA1A in cancers, has not been fully understood. In this review, we summarize the recent studies on the role of EVA1A in different types of cancers, including breast cancer, papillary thyroid cancer, non-small cell lung cancer, hepatocellular carcinoma, glioblastoma and pancreatic cancer, and analyze the relevant mechanisms to provide a theoretical basis for future related research.

【 授权许可】

Unknown